News

One method being used as an alternative to a follow-up bone marrow biopsy in myeloma patients uses plasma cells captured from blood samples. This test will allow the doctor to identify the stage ...
Multiple myeloma is a relatively uncommon cancer of plasma cells ... Using this method, clinicians do not need to perform a bone marrow biopsy, which is easier on the patients. However, bone marrow ...
Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for ...
CT is not necessary for the initial staging of patients with MM, but is useful for directing needle biopsy for ... [80] Bone disease is a hallmark of multiple myeloma (MM), associated with bone ...
Bone marrow biopsy (where a tiny sample is taken out and sent to a lab) Chemotherapy or radiation. If you’re receiving donated bone marrow, you’ll go through a treatment to weaken your immune ...
For decades, the diagnosis of multiple myeloma required evidence of ... 10% infiltration of clonal plasma cells on bone marrow examination or a biopsy-proven bony or extramedullary plasmacytoma.
Aspiration means the doctor or nurse draws some liquid bone marrow up into a syringe. A bone marrow trephine biopsy means they remove a very thin 1 or 2cm long core of bone marrow in one piece. You ...
A 59-year-old woman presented to the emergency department with a left rib fracture and was diagnosed with IgA multiple myeloma. The patient underwent autologous bone-marrow transplantation ...
Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...
including BCMA-targeting bispecific antibodies and CAR-T therapy in multiple myeloma. GenoPredicta is now an LDT test for bone marrow and blood specimens and employs whole genome sequencing (WGS ...